Major Chinese competitor joins the A2 party - Citi

Major Chinese competitor joins the A2 party - Citi
Rebecca Howard
A2 Milk will face increased competition after domestic Chinese infant formula player Junlebao launched an A2-protein formula, Citi said in a note.  The stock is down 3.6 percent at $12.30 and Citi maintains a sell rating on the stock as it sees downside to its consensus margins over the medium term, partly due to increasing competition in China. Other risks include an increasing focus on topline growth over short-term profitability, the investment required to capitalise on the US and China opportunities and regulatory and structural headwind...

More Listed Companies

Numbers and letters for investors
Markets

Simon Robertson: Numbers and letters for investors

A plea for standardised financial reporting from NZX-listed companies.

Simon Robertson 02 Mar 2024
Market watchdog puts Fletcher result under microscope
Markets

Market watchdog puts Fletcher result under microscope

Listed firms sitting on material information a theme of NZ RegCo oversight report.

How Gentrack made its India expansion work
Markets

How Gentrack made its India expansion work

Gentrack has more than 100 staff in Pune, India.

NZME boss calls for digital platform law
Listed Companies

NZME boss calls for digital platform law

NZME CEO Michael Boggs calls for government solution to big tech bargaining imbalance.

Daniel Dunkley 21 Feb 2024